New Drug Targeting Cancer Weakness Shows Great Promise

[News]

Scientists at The Institute of Cancer Research (ICR) and The Royal Marsden Hospital, working with pharmaceutical company AstraZeneca, have completed a Phase I clinical trial demonstrating the great promise of a completely new type of cancer treatment. The results are announced today in The New England Journal of Medicine.

More... (http://www.medicalnewstoday.com/articles/155294.php)